Earnest Partners LLC Bio Rad Laboratories, Inc. Transaction History
Earnest Partners LLC
- $21.5 Billion
- Q4 2024
A detailed history of Earnest Partners LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Earnest Partners LLC holds 618,049 shares of BIO stock, worth $153 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
618,049
Previous 605,549
2.06%
Holding current value
$153 Million
Previous $203 Million
0.21%
% of portfolio
0.95%
Previous 0.92%
Shares
31 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$384 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$258 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$242 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$185 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.1B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...